Novartis

thérapie par cellules souches en Ukraine

Несколько слов о NBScience limited

Несколько слов о NBScience limited: Мы работаем с 2004 по следующим направлениям : 1) GCP ( recherches cliniques) 2) PIB 3) BPF 4) ISO Нашими клиентами в фармацевтическом бизнесе являлись: ФФ Дарница, Фар мак, БХФЗ,Артериум,Novartis, GSK,Pfizer,Jelfa, KRKA,Boehringer Ingelheim,Egis, Genzyme,Actavis, Alambic, Ranbaxy, Ratiopharm, Nycomed, Dr.Reddy’s labs, Reckitt Benckiser Healthcare International , Lire la suite…

Par NBScience, il y a
thérapie par cellules souches en Ukraine

Post-PCI Selection of Antithrombotic Therapy

Post-PCI Selection of Antithrombotic Therapy Improvements in antithrombotic pharmacotherapy have led to important reductions in complications after percutaneous coronary intervention. By John P. Vavalle, MARYLAND, and Robert A. Harrington, MD Since the introduction of percutaneous coronary intervention (PCI) plus que 3 decades ago, the rates of procedural success and associated Lire la suite…

Par NBScience, il y a
thérapie par cellules souches